Volume 11, Issue 5 (2023)
Health Educ Health Promot 2023, 11(5): 695-700 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rabiei H, Rabiei R, Arayeshgari M, Ghasemi T, Sadeghian E. Depression’s Associated Factors in Cancer Patients in Post-COVID-19 Pandemic. Health Educ Health Promot 2023; 11 (5) :695-700
URL: http://hehp.modares.ac.ir/article-5-72903-en.html
URL: http://hehp.modares.ac.ir/article-5-72903-en.html
1- “Neurosurgery Research Group (NRG)” and ”Student Research Committee”, Hamadan University of Medical Sciences, Hamadan, Iran
2- “Department of Nursing, School of Nursing and Midwifery” and “Student Research Committee”, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
4- Clinical Research Development Unit of Shahid Beheshti Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
5- “Department of Nursing, School of Nursing and Midwifery” and “Chronic Diseases (Home care) Research Center”, Hamadan University of Medical Sciences, Hamadan, Iran
2- “Department of Nursing, School of Nursing and Midwifery” and “Student Research Committee”, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
4- Clinical Research Development Unit of Shahid Beheshti Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
5- “Department of Nursing, School of Nursing and Midwifery” and “Chronic Diseases (Home care) Research Center”, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract: (704 Views)
Aims: Quarantine during the COVID-19 pandemic was an important factor in developing depression in cancer patients. Early diagnosing of depression in these patients is a health priority for the medical staff. This study aimed to investigate depression in oncology department patients at the end of the COVID-19 pandemic.
Instrument & Methods: In the present cross-sectional study, the research population included all patients admitted to the oncology department of Shahid Beheshti Hospital and Imam Khomeini Clinic, selected by the convenience sampling method in 2022. Data were collected using a demographic questionnaire and a depression questionnaire. All the analyses of this research were done using SPSS 25 software.
Findings: The Mean depression score was 23.84±9.24. Based on the cutoff points of 13 (mild), 19 (moderate), and 28 (severe) for a total score of depression, 48 patients (16.49%) suffered from mild depression (95%CI: 12.22-20.75), 114 patients (39.17%) suffered from moderate depression (95%CI: 33.56-44.77), and 89 (30.89%) suffered from severe depression (95%CI: 25.29-35.88). The Pearson correlation coefficient also showed significant positive linear correlations between depression and age (r=0.21; p<0.001), age at onset of disease (r=0.20; p=0.001), length of disease (r=0.24; p<0.001) and length of chemotherapy (r=0.14; p=0.016).
Conclusion: Most cancer patients suffer from moderate to severe depression. Since there is a relationship between depression, the duration of the disease, and the duration of chemotherapy, it is recommended to check these patients for depression periodically.
Instrument & Methods: In the present cross-sectional study, the research population included all patients admitted to the oncology department of Shahid Beheshti Hospital and Imam Khomeini Clinic, selected by the convenience sampling method in 2022. Data were collected using a demographic questionnaire and a depression questionnaire. All the analyses of this research were done using SPSS 25 software.
Findings: The Mean depression score was 23.84±9.24. Based on the cutoff points of 13 (mild), 19 (moderate), and 28 (severe) for a total score of depression, 48 patients (16.49%) suffered from mild depression (95%CI: 12.22-20.75), 114 patients (39.17%) suffered from moderate depression (95%CI: 33.56-44.77), and 89 (30.89%) suffered from severe depression (95%CI: 25.29-35.88). The Pearson correlation coefficient also showed significant positive linear correlations between depression and age (r=0.21; p<0.001), age at onset of disease (r=0.20; p=0.001), length of disease (r=0.24; p<0.001) and length of chemotherapy (r=0.14; p=0.016).
Conclusion: Most cancer patients suffer from moderate to severe depression. Since there is a relationship between depression, the duration of the disease, and the duration of chemotherapy, it is recommended to check these patients for depression periodically.
Article Type: Descriptive & Survey |
Subject:
Health Care
Received: 2023/12/12 | Accepted: 2024/04/8 | Published: 2023/05/28
Received: 2023/12/12 | Accepted: 2024/04/8 | Published: 2023/05/28
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. [Link] [DOI:10.3322/caac.21660]
2. Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: A review article. Iran J Public Health. 2018;47(3):309-16. [Link]
3. Belete AM, Alemagegn A, Mulu AT, Yazie TS, Bewket B, Asefa A, et al. Prevalence of depression and associated factors among adult cancer patients receiving chemotherapy during the era of COVID-19 in Ethiopia. Hospital-based cross-sectional study. PLoS One. 2022;17(6):e0270293. [Link] [DOI:10.1371/journal.pone.0270293]
4. Bortolato B, Hyphantis TN, Valpione S, Perini G, Maes M, Morris G, et al. Depression in cancer: The many biobehavioral pathways driving tumor progression. Cancer Treat Rev. 2017;52:58-70. [Link] [DOI:10.1016/j.ctrv.2016.11.004]
5. Chang HA, Barreto N, Davtyan A, Beier E, Cangin MA, Salman J, et al. Depression predicts longitudinal declines in social support among women with newly diagnosed breast cancer. Psycho‐oncology. 2019;28(3):635-42. [Link] [DOI:10.1002/pon.5003]
6. Sudarisan SSP, Abraham B, George C. Prevalence, correlates of depression, and its impact on quality of life of cancer patients attending a palliative care setting in South India. Psycho-oncology. 2019;28(6):1308-13. [Link] [DOI:10.1002/pon.5083]
7. Gan GG, Ng DLC, Leong YC, Bee PC, Chin EF, Abdul Halim H. Anxiety and depression in patients with haematological neoplasms in Malaysia. Med J Malaysia. 2019;74(3):191-7. [Link]
8. Polikandrioti M, Evaggelou E, Zerva S, Zerdila M, Koukoularis D, Kyritsi E. Evaluation of depression in patients undergoing chemotherapy. Health Sci J. 2008;2(3):162-72. [Link]
9. Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20(7):1907-17. [Link] [DOI:10.1200/JCO.2002.07.101]
10. Krebber AMH, Buffart LM, Kleijn G, Riepma IC, De Bree R, Leemans CR, et al. Prevalence of depression in cancer patients: A meta‐analysis of diagnostic interviews and self‐report instruments. Psycho‐oncology. 2014;23(2):121-30. [Link] [DOI:10.1002/pon.3409]
11. Pinquart M, Duberstein PR. Depression and cancer mortality: A meta-analysis. Psychol Med. 2010;40(11):1797-810. [Link] [DOI:10.1017/S0033291709992285]
12. So WKW, Marsh G, Ling WM, Leung FY, Lo JCK, Yeung M, et al. Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs. 2010;14(1):17-22. [Link] [DOI:10.1016/j.ejon.2009.07.005]
13. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: A meta‐analysis. Cancer. 2009;115(22):5349-61. [Link] [DOI:10.1002/cncr.24561]
14. Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev. 2018;(4):CD011006. [Link] [DOI:10.1002/14651858.CD011006.pub3]
15. Irwin MR. Depression and insomnia in cancer: Prevalence, risk factors, and effects on cancer outcomes. Curr Psychiatry Rep. 2013;15(11):404. [Link] [DOI:10.1007/s11920-013-0404-1]
16. Sotelo JL, Musselman D, Nemeroff C. The biology of depression in cancer and the relationship between depression and cancer progression. Int Rev Psychiatry. 2014;26(1):16-30. [Link] [DOI:10.3109/09540261.2013.875891]
17. Caruso R, Nanni MG, Riba MB, Sabato S, Grassi L. The burden of psychosocial morbidity related to cancer: Patient and family issues. Int Rev Psychiatry. 2017;29(5):389-402. [Link] [DOI:10.1080/09540261.2017.1288090]
18. Wang X, Wang N, Zhong L, Wang S, Zheng Y, Yang B, et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: A systematic review and meta-analysis of 282,203 patients. Mol Psychiatry. 2020;25(12):3186-97. [Link] [DOI:10.1038/s41380-020-00865-6]
19. Wang YH, Li JQ, Shi JF, Que JY, Liu JJ, Lappin JM, et al. Depression and anxiety in relation to cancer incidence and mortality: A systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020;25(7):1487-99. [Link] [DOI:10.1038/s41380-019-0595-x]
20. Farpour HR, Hoveidaei AH, Habibi L, Moosavi M, Farpour S. The impact of social media use on depression in multiple sclerosis patients. Acta Neurol Belg. 2020;120(6):1405-9. [Link] [DOI:10.1007/s13760-020-01407-1]
21. Mohsenpour MA, Mohammadi F, Razmjooei N, Eftekhari MH, Hejazi N. Milk kefir drink may not reduce depression in patients with non-alcoholic fatty liver disease: Secondary outcome analysis of a randomized, single-blinded, controlled clinical trial. BMC Nutr. 2023;9:80. [Link] [DOI:10.1186/s40795-023-00732-x]
22. Omidian M, Mahmoudi M, Abshirini M, Eshraghian MR, Javanbakht MH, Zarei M, et al. Effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: Randomized placebo-controlled double-blind clinical trial. Diabetes Metab Syndr. 2019;13(4):2375-80. [Link] [DOI:10.1016/j.dsx.2019.06.011]
23. Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian-language version of the Beck Depression Inventory-Second edition: BDI-II-PERSIAN. Depress Anxiety. 2005;21(4):185-92. [Link] [DOI:10.1002/da.20070]
24. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30(4):377-99. [Link] [DOI:10.1002/sim.4067]
25. Aryankhesal A, Ghashghaee A, Sardari E, Mahmoudi S, Alihosseini S, Dehnad A, et al. Prevalence of depression in patients with cancer in Iran: A systematic review and meta-analysis. BMJ Support Palliat Care. 2022;12(e4):e518-25. [Link] [DOI:10.1136/bmjspcare-2018-001724]
26. Darvishi N, Ghasemi H, Rahbaralam Z, Shahrjerdi P, Akbari H, Mohammadi M. The prevalence of depression and anxiety in patients with cancer in Iran: A systematic review and meta-analysis. Support Care Cancer. 2022;30(12):10273-84. [Link] [DOI:10.1007/s00520-022-07371-1]
27. Derakhshanfar A, Niayesh A, Abbasi M, Ghalaeeha A, Shojaee M. Frequency of depression in breast cancer patients: A study in Farshchianand Besat Hospitals of Hamedan during 2007-8. Iran J Surg. 2013;21(2):68-74. [Persian] [Link]
28. Adzrago D, Sulley S, Tagoe I, Ormiston CK, Odame EA, Mamudu L, et al. Assessment of anxiety/depression among cancer patients before and during the COVID-19 pandemic. Psycho-oncology. 2022;31(10):1681-91. [Link] [DOI:10.1002/pon.6026]
29. Bakhiet TE, Ali SM, Bakhiet AM. Prevalence of depression and anxiety among adult patients undergoing chemotherapy in Khartoum, Sudan: A cross-sectional study. J Affect Disord Rep. 2021;6:100218. [Link] [DOI:10.1016/j.jadr.2021.100218]
30. Ayalew M, Deribe B, Duko B, Geleta D, Bogale N, Gemechu L, et al. Prevalence of depression and anxiety symptoms and their determinant factors among patients with cancer in southern Ethiopia: A cross-sectional study. BMJ Open. 2022;12(1):e051317. [Link] [DOI:10.1136/bmjopen-2021-051317]
31. Naser AY, Hameed AN, Mustafa N, Alwafi H, Dahmash EZ, Alyami HS, et al. Depression and anxiety in patients with cancer: A cross-sectional study. Front Psychol. 2021;12:585534. [Link] [DOI:10.3389/fpsyg.2021.585534]
32. Taghavi M, Kalafi E, Talei AR, Dehbozorgi G, Taghavi SM. Investigating the relation of depression and religious coping and social support in women with breast cancer. J Isfahan Med Sch. 2011;28(115):901-8. [Persian] [Link]
33. Heidarirad F, Yarahmadi M, Heidarirad H, Shafiei M. Evaluation of prevalence of depression and its related factors among women with breast cancer referred to the radiotherapy center of Tawhid Hospital of Sanandaj, Iran in 2017. Sci J Nurs Midwifery Paramed Fac. 2018;4(2):39-49. [Persian] [Link]
34. Rajabizadeh G, Mansoori SM, Shakibi MR, Ramezani MR. Determination of factors related to depression in cancer patients of the oncology ward in Kerman. J Kerman Univ Med Sci. 2005;12(4):142-7. [Persian] [Link]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |